GREM1, a profibrotic mediator, was upregulated in BLM-treated mice and IPF patients (Figure 3C,D) and DMB downregulated GREM1 protein expression level (Figure 3E,F). This evidence concerns the gene GREM1 and idiopathic pulmonary fibrosis.